PPLPHARMA Quarterly Results, Profit & Loss, Balance Sheet (PPLPHARMA)

PPLPHARMA quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • PPLPHARMA Financials
  • PPLPHARMA Shareholding Pattern
  • PPLPHARMA Earnings Documents
  • PPLPHARMA Announcements
  • PPLPHARMA Corporate Actions
  • PPLPHARMA Bulk, Block & Insider Deals
  • PPLPHARMA Delivery Data
  • PPLPHARMA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Piramal Pharma Ltd (PPLPHARMA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Piramal Pharma Ltd reported sales of ₹2,617.06 Cr, operating profit of ₹348.74 Cr (OPM 13.33%) and net profit of ₹5.03 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

PPLPHARMA quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales2,204.222,754.071,933.712,043.722,139.872,751.772,269.922,617.06
Expenses1,866.482,193.081,827.011,885.031,944.142,291.262,074.722,268.32
Operating Profit337.74560.99106.7158.69195.73460.51195.2348.74
OPM15.32%20.37%5.52%7.76%9.15%16.74%8.6%13.33%
Other Income29.1858.2597.7180.3912.39-116.14108.9753.67
Interest103.31103.6886.1582.4289.2482.9988.0887.63
Depreciation196.81242.76197.28202.84212.74218.38223.55233.15
Profit before tax66.8272.8-79.02-46.18-93.8643-7.4681.63
Tax94.49%43.73%3.39%114.85%45.1%120.53%830.16%93.84%
Net Profit3.68153.5-81.7-99.22-136.19-8.83-69.395.03
EPS in Rs0.031.16-0.61-0.75-1.02-0.07-0.520.04
PPLPHARMA profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6,5597,0828,1719,1518,8699,779
Expenses5,6096,4536,9747,7067,9478,578
Operating Profit9506291,1971,4459221,200
OPM14%9%15%16%10%12%
Other Income3192721722087459
Interest198344448422341348
Depreciation586677741816831888
Profit before tax485-120179415-17623
Tax22%55%90%78%85%-
Net Profit376-1861891-326-209
EPS in Rs--1.410.130.69-2.45-1.57
Dividend Payout18%0%82%20%0%-
PPLPHARMA balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital1,3231,3241,3261,3271,328
Reserves6,5886,8016,7486,8356,814
Borrowings4,7104,8564,8515,6755,873
Other Liabilities2,4612,4473,2653,7704,522
Total Liabilities15,08315,42916,18917,60718,537
Fixed Assets7,9908,1338,8278,6849,483
CWIP1,1169775671,100966
Investments385291442437434
Other Assets5,5926,0286,3537,3867,655
Total Assets15,08315,42916,18917,60718,537
PPLPHARMA cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity7664841,0058921,653
Cash from Investing Activity-1,737-1,334-416-488-820
Cash from Financing Activity794818-422-441-39
Net Cash Flow-177-32166-37794
Free Cash Flow-91-461294233776
CFO/OP98%107%97%85%202%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit981079785202
PPLPHARMA ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days9993959489
Inventory Days207227269261345
Days Payable153161190173279
Cash Conversion Cycle153159174182155
Working Capital Days3613216044
ROCE7%2%5%6%3%
  • PPLPHARMA Shareholding Pattern
  • PPLPHARMA Earnings Concalls
  • PPLPHARMA Growth Catalysts
  • PPLPHARMA Corporate Actions
  • PPLPHARMA Announcements
  • PPLPHARMA Results & Documents
  • PPLPHARMA Bulk & Block Deals
  • PPLPHARMA Delivery Data